
|Articles|August 15, 2003
Drug therapy may enhance outcomes of retinal repair
Fort Lauderdale, FL-Pharmacologic enhancement for retinal repair surgery continues to be a viable strategy, and the promise of its use to improve outcomes may be fulfilled as drug therapy enters a new era, said Mark S. Blumenkranz, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
3
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
4
REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy
5

























